Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether duloxetine is an effective treatment of attention deficit disorder in adults.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Université de Montréal
• Collaborator: Centre hospitalier de l'Université de Montréal (CHUM)
• Treatments: Duloxetine Hydrochloride

Criteria

Inclusion Criteria:

• Clinical diagnosis of ADHD of at least moderate intensity

• Able to give consent

• Able to swallow capsules

Exclusion Criteria:

• Allergic or do not tolerate duloxetine

• Under psychotherapy for ADHD

• Taking a medication that interacts with duloxetine, including all psychotropic medication

• Treated with medication for ADHD

• Unstable medical condition

• Severe renal insufficiency

• Liver insufficiency

• Substance/alcool abuse or dependency in the last 6 months

• Pregnancy, nursing or inadequate contraceptive methods

• Suicide or homicide risk

• Organic brain syndrome

• Any diagnosis of lifetime bipolar disorder or psychotic disorder, and any actual diagnosis of anxious disorder or major depressive disorder